Table 4 Univariate and multivariate analyses of the factor associated with any stroke recurrence.

From: Long-term outcomes of patients with embolic stroke of undetermined source according to subtype

 

Univariable analysis

Multivariable analysis

HR (95% CI)

P value

HR (95% CI)

P value

Demographics

Age, year

1.029 (1.009–1.050)

0.005

1.016 (0.994–1.039

0.153

Sex, men

1.814 (1.049–3.137)

0.033

1.386 (0.780–2.463)

0.265

Risk factors

Hypertension

1.441 (0.823–2.523)

0.200

  

Diabetes

1.806 (1.113–2.929)

0.017

1.505 (0.914–2.478)

0.108

Hypercholesterolemia

1.195 (0.664–2.150)

0.553

  

Current smoker

0.709 (0.394–1.276)

0.252

  

Previous stroke

3.480 (2.119–5.714)

 < 0.001

2.884 (1.716–4.847)

 < 0.001

Initial NIHSS score

0.984(0.912–1.062)

0.679

  

Laboratory findings

White blood cell

1.000 (1.000–1.000)

0.592

  

Platelet

0.994 (0.990–0.998)

0.007

0.996 (0.992–1.001)

0.093

Total cholesterol

0.998(0.993–1.003)

0.504

  

Triglyceride

1.001 (0.999–1.003)

0.464

  

HDL

0.979 (0.956–1.003)

0.083

  

LDL

0.997 (0.990–1.004)

0.386

  

ESUS classification

Minor cardioembolic source

Ref

0.044

Ref

0.177

No cause

1.281 (0.637–2.577)

0.487

1.292 (0.639–2.613)

0.475

Two or more causes

1.389 (0.685–2.819)

0.362

1.084 (0.528–2.229)

0.825

Non-stenotic (< 50%) relevant artery plaque

1.433 (0.601–3.417)

0.417

1.056 (0.439–2.543)

0.903

Complex aortic plaque

3.220 (1.486–6.977)

0.003

2.470 (1.108–5.508)

0.027

  1. Cox proportional hazards regression analysis was conducted after adjusting for variables that were significant (p < 0.05) in the univariable analysis along with the ESUS subtype.
  2. HR hazard ratio, CI confidence interval, NIHSS National Institutes of Health Stroke Scale, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, Ref reference.